Assignee
OXIGENE INC
US17 patents
Top patents by PatentIndex Score
US6538038B1Mar 25, 2003
Compositions and methods for use in targeting vascular destruction
OXIGENE INC63 citations94
US6020351AFeb 1, 2000
Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
OXIGENE INC32 citations92
US6339073B1Jan 15, 2002
Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases
OXIGENE INC18 citations84
US6100299AAug 8, 2000
N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
OXIGENE INC8 citations73
US6028111AFeb 22, 2000
Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
OXIGENE INC11 citations71
US7384925B2Jun 10, 2008
Functionalized stilbene derivatives as improved vascular targeting agents
OXIGENE INC6 citations70
US8877967B2Nov 4, 2014
Compositions and methods for inhibition of cathepsins
OXIGENE INC4 citations68
US6956054B2Oct 18, 2005
Compositions and methods for use in targeting vascular destruction
OXIGENE INC4 citations62
US5561129AOct 1, 1996
Methods of administering phenothiazines and/or acid addition salts thereof
OXIGENE INC2 citations62
US5561161AOct 1, 1996
Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof
OXIGENE INC3 citations62
US7358236B1Apr 15, 2008
Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents
OXIGENE INC5 citations60
US6773702B2Aug 10, 2004
Use of combretastatin A4 and its prodrugs as an immune enhancing therapy
OXIGENE INC5 citations57
US9458103B2Oct 4, 2016
Compositions and methods for inhibition of cathepsins
OXIGENE INC2 citations56
US6743937B2Jun 1, 2004
Efficient method of synthesizing combretastatin A-4 prodrugs
OXIGENE INC4 citations54
USRE45907EMar 1, 2016
Functionalized stilbene derivatives as improved vascular targeting agents
OXIGENE INC0 citations49
USRE45720EOct 6, 2015
Functionalized stilbene derivatives as improved vascular targeting agents
OXIGENE INC0 citations49
US6713517B1Mar 30, 2004
Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
OXIGENE INC1 citations49